Atreca is a privately held company developing novel therapeutics based on a deep understanding of the human immune response. They focus in a unique way on the immune responses of patients in therapeutic areas where such responses are the key phenomenon driving clinical outcomes, enabling us to discover and develop novel immunotherapies, including those in our lead programs in oncology.
